Glucagon-Like Peptide-1 Receptor Agonist-Experienced Adults with Type 2 Diabetes Switching to Once-Weekly Semaglutide in a Real-World Setting: SURE Program Post Hoc Analysis. - Rudofsky G; Menzen M; Potier L; Catarig AM; Clark A; Priyadarshini P; Abreu C (Advances in therapy, 2025)